Literature DB >> 31891447

Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study.

Yook-Chin Chia1,2, Kazuomi Kario3,4, Naoko Tomitani3, Sungha Park5, Jinho Shin6, Yuda Turana7, Jam Chin Tay8, Peera Buranakitjaroen9, Chen-Huan Chen10, Satoshi Hoshide3, Jennifer Nailes11, Huynh Van Minh12, Saulat Siddique13, Jorge Sison14, Arieska Ann Soenarta15, Guru Prasad Sogunuru16,17, Apichard Sukonthasarn18, Boon Wee Teo19, Narsingh Verma20, Yuqing Zhang21, Tzung-Dau Wang22, Ji-Guang Wang23.   

Abstract

Blood pressure variability (BPV) has been shown to be independently associated with cardiovascular (CV) mortality and morbidity. Patients with type 2 diabetes mellitus (T2DM) have also been shown to have increased BPV. We aimed to compare BPV in hypertensive patients with diabetes with those without diabetes. A total of 1443 hypertensive patients measured their blood pressure (BP) twice in the morning and twice before bed at home for a week. Demographic data, history of T2DM, and anti-hypertensive use were captured. Clinic BP was measured twice in the clinic. Control of BP was defined as clinic systolic BP (SBP) <140 mm Hg and home SBP < 135 mm Hg. BPV was based on home SBP measurements. A total of 362(25.1%) hypertensives had diabetes and 47.4% were male. Mean age was 62.3 ± 12.1 years. There was no difference in the mean clinic SBP in both groups (139.9 mm Hg vs 138.4 mm Hg P = .188). However, the mean morning home SBP was significantly higher and control rate lower in hypertensives with diabetes than those without (132.3 ± 15 mm Hg vs 129.7 ± 14.4 mm Hg P = .005, 39.4% vs 47.6% P = .007), respectively. Masked uncontrolled morning hypertension was higher in those with diabetes versus those without (12.8% vs 8.4%, respectively). There was no statistically significant difference in BPV between those with and without diabetes. In summary, clinic SBP was similar in hypertensives with or without diabetes. However, control of BP based on both clinic and home SBP thresholds was poorer in hypertensives with diabetes compared to those without. Masked uncontrolled morning hypertension was higher in those with diabetes than those without. There was no difference in BPV between the two groups.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Asia BP@Home; blood pressure variability ; home BP measurement ; masked hypertension; type 2 diabetes mellitus

Mesh:

Year:  2019        PMID: 31891447      PMCID: PMC8030068          DOI: 10.1111/jch.13731

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  Blood pressure variability in hypertension: a possible cardiovascular risk factor.

Authors:  Kazuomi Kario
Journal:  Am J Hypertens       Date:  2004-11       Impact factor: 2.689

2.  A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy.

Authors:  Kouichi Tamura; Yuko Tsurumi; Masashi Sakai; Yutaka Tanaka; Yasuko Okano; Junji Yamauchi; Tomoaki Ishigami; Minoru Kihara; Nobuhito Hirawa; Yoshiyuki Toya; Machiko Yabana; Yasuo Tokita; Toshimasa Ohnishi; Satoshi Umemura
Journal:  Clin Exp Hypertens       Date:  2007-01       Impact factor: 1.749

3.  Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes.

Authors:  Juan Ruiz; David Monbaron; Gianfranco Parati; Sophie Perret; Erik Haesler; Claude Danzeisen; Daniel Hayoz
Journal:  Hypertension       Date:  2005-05-31       Impact factor: 10.190

4.  Determinants of masked hypertension in the general population: the Finn-Home study.

Authors:  Marjo-Riitta A Hänninen; Teemu J Niiranen; Pauli J Puukka; Aino K Mattila; Antti M Jula
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

Review 5.  Effects of Antihypertensive Therapy on Blood Pressure Variability.

Authors:  Kazuo Eguchi
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

6.  Home blood pressure variability as cardiovascular risk factor in the population of Ohasama.

Authors:  Kei Asayama; Masahiro Kikuya; Rudolph Schutte; Lutgarde Thijs; Miki Hosaka; Michihiro Satoh; Azusa Hara; Taku Obara; Ryusuke Inoue; Hirohito Metoki; Takuo Hirose; Takayoshi Ohkubo; Jan A Staessen; Yutaka Imai
Journal:  Hypertension       Date:  2012-11-19       Impact factor: 10.190

7.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

8.  Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regions.

Authors:  Kazuomi Kario; Naoko Tomitani; Peera Buranakitjaroen; Chen-Huan Chen; Yook-Chin Chia; Romeo Divinagracia; Sungha Park; Jinho Shin; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Yuda Turana; Ji-Guang Wang; Lawrence Wong; Yuqing Zhang; Sirisawat Wanthong; Satoshi Hoshide; Hiroshi Kanegae
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-18       Impact factor: 3.738

9.  Long-Term Visit-to-Visit Blood Pressure Variability and Renal Function Decline in Patients With Hypertension Over 15 Years.

Authors:  Yook Chin Chia; Hooi Min Lim; Siew Mooi Ching
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

Review 10.  Blood pressure variability and cardiovascular disease: systematic review and meta-analysis.

Authors:  Sarah L Stevens; Sally Wood; Constantinos Koshiaris; Kathryn Law; Paul Glasziou; Richard J Stevens; Richard J McManus
Journal:  BMJ       Date:  2016-08-09
View more
  2 in total

1.  Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study.

Authors:  Yook-Chin Chia; Kazuomi Kario; Naoko Tomitani; Sungha Park; Jinho Shin; Yuda Turana; Jam Chin Tay; Peera Buranakitjaroen; Chen-Huan Chen; Satoshi Hoshide; Jennifer Nailes; Huynh Van Minh; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Boon Wee Teo; Narsingh Verma; Yuqing Zhang; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-31       Impact factor: 3.738

Review 2.  The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.